Skip to main content
. 2015 Nov 2;6:556. doi: 10.3389/fimmu.2015.00556

Figure 5.

Figure 5

Comparison of the CD94 immune phenotype and Hsp70 serum levels in squamous cell and adeno NSCLC patients. (A) Correlation of the CD94 expression and serum Hsp70 levels in squamous cell NSCLC patients (n = 25) (patient collective #1). NSCLC patients were divided in a group with low (≤8.5% CD3/CD94+ NK cells; median Hsp70 level: 17.45 ng/ml; 95th percentile: 59.00 ng/ml) and high (>8.5% CD3/CD94+ NK cells; median Hsp70 level: 10.45 ng/ml; 95th percentile: 17.70 ng/ml) percentage of CD3/CD94+ NK cells; *p < 0.05 (Mann–Whitney U-test). (B) Correlation of the CD94 expression and serum Hsp70 levels in adeno NSCLC patients (n = 18) (patient collective #1). NSCLC patients were divided in a group with low (≤6.5% CD3/CD94+ NK cells; median Hsp70 level: 12.15 ng/ml; 95th percentile: 40.20 ng/ml) and high (>6.5% CD3/CD94+ NK cells; median Hsp70 level: 12.35 ng/ml; 95th percentile: 22.50 ng/ml) percentage of CD3/CD94+ NK cells; *p < 0.05 (Mann–Whitney U-test).